Market Overview:
The global oligo synthesizer market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for oligonucleotides in various applications such as laboratory research, biopharmaceuticals, and synthesis services. Additionally, the growing focus on personalized medicine is also contributing to the growth of this market. Based on type, the global oligo synthesizer market can be segmented into laboratory type and large-scale synthesis type. The laboratory type segment is expected to account for a larger share of this market than the large-scale synthesis type segment during the forecast period. This can be attributed to factors such as lower cost and easy availability of these instruments relative to large-scale synthesis types. Based on application, the global oligo synthesizer market can be divided into laboratory research and development (R&D), biopharmaceutical companies, and synthetic services companies.
Product Definition:
An oligo synthesizer is a machine or software used to create oligonucleotides. Oligonucleotides are short, synthetic DNA or RNA molecules that have many potential uses in research and medicine. The importance of oligo synthesizers lies in their ability to quickly and easily create these complex molecules for use in the lab.
Laboratory Type:
The global oligo synthesizer market is expected to witness significant growth over the forecast period owing to its increasing demand in the R&D activities of biotechnology and pharmaceutical industries. Oligosynthesis is a process used for synthesis of large number of short peptide sequences, which are then used for research purposes by various pharmaceutical companies and academic institutes.
Large scale Synthesis Type:
Large scale synthesis type is used for the production of longer oligos with high accuracy and specificity. It uses a combination of chemical, enzymatic, and mechanical methods for the construction of long oligos. The most common method used in this process is PCR (polymerase chain reaction) which involves a series of reactions between specific sets of DNA molecules to produce an exponential increase in length.
Application Insights:
The global demand for oligo synthesizers has witnessed a paradigm shift due to the development of novel products with enhanced performance. The laboratory-based oligo synthesizers dominated the market in terms of revenue share in 2017 owing to their low cost and easy operation. These devices are used for small scale research projects or individual compound libraries where a high degree of accuracy is not required. However, these devices cannot be used on a commercial level as they lack features such as multi-components synthesis, large scale manufacturing facilities and advanced software support systems required by modern biopharmaceutical companies.
Owing to the increasing need for drug compounds at an affordable cost, companies have started collaborating with external vendors engaged in compound preparation through oligomeric intermediates or other intermediate compounds (such as furan resin) instead of purchasing them directly from chemical suppliers which can result in substantial savings along with ease.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of research laboratories and biopharmaceutical companies in this region has led to an increase in demand for oligosynthesis services. Moreover, increasing R&D activities on drug discovery and development are expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness significant growth over the forecast period owing to rising investments by various pharmaceutical companies for drug discovery & development activities coupled with growing healthcare spending by governments across emerging economies such as China, India, Singapore, Thailand and Malaysia among others.
Growth Factors:
- Increasing demand for oligonucleotides in drug discovery and development
- Rising prevalence of genetic disorders
- Growing application of oligonucleotides in diagnostics
- Technological advancements in oligonucleotide synthesis platforms
- Increasing investments by pharmaceutical and biotechnology companies for R&D activities
Scope Of The Report
Report Attributes
Report Details
Report Title
Oligo Synthesizer Market Research Report
By Type
Laboratory Type, Large scale Synthesis Type
By Application
Laboratory, Biopharmaceutical Company, Synthesis Services Company
By Companies
CS Bio, Biolytic Lab Performance, IDT, BioAutomation, GE Healthcare Life Sciences, Polygen GmbH, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Oligo Synthesizer Market Report Segments:
The global Oligo Synthesizer market is segmented on the basis of:
Types
Laboratory Type, Large scale Synthesis Type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratory, Biopharmaceutical Company, Synthesis Services Company
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CS Bio
- Biolytic Lab Performance
- IDT
- BioAutomation
- GE Healthcare Life Sciences
- Polygen GmbH
- Thermo Fisher Scientific
Highlights of The Oligo Synthesizer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Laboratory Type
- Large scale Synthesis Type
- By Application:
- Laboratory
- Biopharmaceutical Company
- Synthesis Services Company
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oligo Synthesizer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oligo Synthesizer is a software synthesizer that allows users to create music using a variety of sounds. It is available for both Windows and Mac platforms.
Some of the key players operating in the oligo synthesizer market are CS Bio, Biolytic Lab Performance, IDT, BioAutomation, GE Healthcare Life Sciences, Polygen GmbH, Thermo Fisher Scientific.
The oligo synthesizer market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oligo Synthesizer Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oligo Synthesizer Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oligo Synthesizer Market - Supply Chain
4.5. Global Oligo Synthesizer Market Forecast
4.5.1. Oligo Synthesizer Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oligo Synthesizer Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oligo Synthesizer Market Absolute $ Opportunity
5. Global Oligo Synthesizer Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oligo Synthesizer Market Size and Volume Forecast by Type
5.3.1. Laboratory Type
5.3.2. Large scale Synthesis Type
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oligo Synthesizer Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oligo Synthesizer Market Size and Volume Forecast by Application
6.3.1. Laboratory
6.3.2. Biopharmaceutical Company
6.3.3. Synthesis Services Company
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oligo Synthesizer Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oligo Synthesizer Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oligo Synthesizer Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oligo Synthesizer Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oligo Synthesizer Demand Share Forecast, 2019-2026
9. North America Oligo Synthesizer Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oligo Synthesizer Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oligo Synthesizer Market Size and Volume Forecast by Application
9.4.1. Laboratory
9.4.2. Biopharmaceutical Company
9.4.3. Synthesis Services Company
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oligo Synthesizer Market Size and Volume Forecast by Type
9.7.1. Laboratory Type
9.7.2. Large scale Synthesis Type
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oligo Synthesizer Demand Share Forecast, 2019-2026
10. Latin America Oligo Synthesizer Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oligo Synthesizer Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oligo Synthesizer Market Size and Volume Forecast by Application
10.4.1. Laboratory
10.4.2. Biopharmaceutical Company
10.4.3. Synthesis Services Company
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oligo Synthesizer Market Size and Volume Forecast by Type
10.7.1. Laboratory Type
10.7.2. Large scale Synthesis Type
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oligo Synthesizer Demand Share Forecast, 2019-2026
11. Europe Oligo Synthesizer Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oligo Synthesizer Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oligo Synthesizer Market Size and Volume Forecast by Application
11.4.1. Laboratory
11.4.2. Biopharmaceutical Company
11.4.3. Synthesis Services Company
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oligo Synthesizer Market Size and Volume Forecast by Type
11.7.1. Laboratory Type
11.7.2. Large scale Synthesis Type
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
1.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oligo Synthesizer Demand Share, 2019-2026
12. Asia Pacific Oligo Synthesizer Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oligo Synthesizer Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oligo Synthesizer Market Size and Volume Forecast by Application
12.4.1. Laboratory
12.4.2. Biopharmaceutical Company
12.4.3. Synthesis Services Company
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oligo Synthesizer Market Size and Volume Forecast by Type
12.7.1. Laboratory Type
12.7.2. Large scale Synthesis Type
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oligo Synthesizer Demand Share, 2019-2026
13. Middle East & Africa Oligo Synthesizer Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oligo Synthesizer Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oligo Synthesizer Market Size and Volume Forecast by Application
13.4.1. Laboratory
13.4.2. Biopharmaceutical Company
13.4.3. Synthesis Services Company
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oligo Synthesizer Market Size and Volume Forecast by Type
13.7.1. Laboratory Type
13.7.2. Large scale Synthesis Type
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oligo Synthesizer Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oligo Synthesizer Market: Market Share Analysis
14.2. Oligo Synthesizer Distributors and Customers
14.3. Oligo Synthesizer Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. CS Bio
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Biolytic Lab Performance
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. IDT
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. BioAutomation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. GE Healthcare Life Sciences
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Polygen GmbH
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Thermo Fisher Scientific
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
